Prosecution Insights
Last updated: April 19, 2026
Application No. 18/783,075

MEDICAL TOOLS FOR CORNEAL TISSUE DELIVERY

Non-Final OA §102§103
Filed
Jul 24, 2024
Examiner
IGBOKO, CHIMA U
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Corneagen
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
3y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
319 granted / 408 resolved
+8.2% vs TC avg
Strong +41% interview lift
Without
With
+40.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
44 currently pending
Career history
452
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
42.6%
+2.6% vs TC avg
§102
29.5%
-10.5% vs TC avg
§112
21.8%
-18.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 408 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-20 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Walter et al. (US 2014/0142587) in view of Schneider et al. (US 2013/0023892). Regarding claim 1, an invention relating corneal implant device, Walter discloses (Figs. 8A, 16, 20A-C, 22, 34-37) a donor corneal tissue storage and delivery device (10), comprising: a storage fluid (92; Par. 0153); a cannula (60) having a proximal end [i.e. end within element 10b] and a distal end (see annotated figure below); at least one fluid channel (150) with a proximal end [i.e. at the luer lock] and a distal end (see annotated figure below), the distal end disposed within the proximal end of the cannula (Par. 0125-0126); a flexible support (15) configured to receive a donor corneal tissue and retract into the cannula (Par. 0118); a retractor assembly (16) coupled to the flexible support (Par. 0092) and operable to retract the coupled flexible support thereby retracting the donor corneal tissue into the cannula (Par. 0121); a deployment assembly (65) coupled to the cannula (Par. 0118) and configured to retract the cannula and deliver the donor corneal tissue to an implantation site from the flexible support retracted into the cannula (Par. 0121-0123); and a removable reservoir [i.e. cap] removably coupled to the deployment assembly and in fluid communication with the at least one fluid channel (Par. 0110), wherein the removable reservoir is configured to receive the storage fluid for hydrating the donor corneal tissue received by the flexible support while the flexible support is retracted into the cannula, wherein the at least one fluid channel, the cannula, and the removable reservoir are all filled with the storage fluid (Par. 0125-0126). PNG media_image1.png 312 470 media_image1.png Greyscale In the alternative and the analogous art of corneal implant device, Schneider discloses (Fig. 1) a removable reservoir [i.e. cap (300)] removably coupled to a deployment assembly (310), wherein the removable reservoir is configured to receive a storage fluid for hydrating a donor corneal tissue (320) retracted into the deployment assembly (Par. 0040-0041). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Walter to have a removable reservoir removably coupled to the deployment assembly and in fluid communication with the at least one fluid channel, wherein the removable reservoir is configured to receive the storage fluid for hydrating the donor corneal tissue received by the flexible support while the flexible support is retracted into the cannula, as taught by Schneider. Walter discloses a removable reservoir [i.e. cap] is desired (Par. 0110), thus Schneider’s removable reservoir would have provided Walter with a sufficient means for removably coupling to the deployment assembly and receiving a storage fluid for hydrating a donor corneal tissue retracted into the cannula. Regarding claim 2, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter discloses (Fig. 20A) further comprising a housing (10b) having a proximal end (10p) and a distal end (see annotated figure below), wherein the cannula is disposed at and tapers towards the distal end of the housing (Par. 0117). PNG media_image2.png 307 508 media_image2.png Greyscale Regarding claim 3, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 2. Walter further discloses wherein the cannula is slidably retractable relative to the housing (Par. 0117), and wherein the deployment assembly is configured to inhibit axial retraction of the cannula (Par. 0121). Regarding claim 4, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 3. Walter discloses (Fig. 20A) further comprising a locking guard member (73) in communication with the deployment assembly and configured to inhibit axial retraction of the cannula (Par. 0121). Regarding claim 5, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 4. Walter further discloses wherein the locking guard member is removable from the housing to allow the deployment assembly to retract the cannula into the housing, and wherein the at least one fluid channel remains stationary within the retracting cannula and acts to push the donor corneal tissue out of the cannula (Par. 0121-0123). Regarding claim 6, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses (Figs. 8A & 20A) wherein the retractor assembly comprises a retractor shaft (16) coupled to the flexible support (15) and one or more loading members (72) coupled to the retractor shaft and operable to retract the retractor shaft and coupled flexible support thereby retracting the flexible support and donor corneal tissue into the cannula (Par. 0121). Regarding claim 7, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 6. Walter discloses (Fig. 20A) further comprising a housing (10b) having a proximal end (10p) and a distal end (see annotated figure below), wherein the cannula is disposed at the distal end of the housing, and wherein the one or more loading members of the retractor assembly are held by the housing (Par. 0118 & 0121). PNG media_image2.png 307 508 media_image2.png Greyscale Regarding claim 8, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses (Fig. 20A) wherein the deployment assembly comprises a deployment shaft (65) coupled to the cannula and one or more deployment members [i.e. slide control used to retract elements 60 and 65] coupled to the deployment shaft and operable to cause the deployment shaft to retract the cannula and to deliver the donor corneal tissue to an implantation site from the flexible support retracted into the cannula (Par. 0121-0123). Regarding claim 9, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 8. Walther discloses (Fig. 20A) further comprising a housing (10b) having a proximal end (10p) and a distal end (see annotated figure below), wherein the cannula is disposed at the distal end of the housing, and wherein the deployment shaft of the deployment assembly is configured to retract into the distal end of the housing (Par. 0118 & 0121-0123). PNG media_image2.png 307 508 media_image2.png Greyscale Regarding claim 10, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses wherein the at least one fluid channel is configured to receive irrigation fluid and direct the irrigation fluid to the cannula to provide irrigation to the donor corneal tissue and the implantation site and configured to help flowably deliver the donor corneal tissue when the deployment assembly is operated (Par. 0125-0126). Regarding claim 11, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter discloses (Fig. 20A) further comprising a fluid channel connector (74) coupled to the proximal end of the at least one fluid channel and a fluid pressure source [i.e. syringe] configured to releasably engage the fluid channel connector to help deliver the donor corneal tissue into a small incision scleral access site (Par. 0126). Regarding claims 12-13, Walter, as modified by in the alternative by Schneider, discloses wherein the removable reservoir contains the storage fluid, wherein the storage fluid comprises a biocompatible fluid [Claim 12]; wherein the biocompatible fluid is a cornea storage solution [Claim 13] (Par. 0125-0126) [i.e. storage solution, see Schneider paragraph 0040-0041]. Regarding claim 14, Walter, as modified by in the alternative by Schneider, further discloses wherein the removable reservoir comprises a reservoir base configured to removably couple the removable reservoir to a distal end of the deployment assembly, a reservoir body extending distally from the reservoir base, and a reservoir cap distal the reservoir base, the reservoir cap removably coupled to the reservoir body [i.e. inserter cap (300), see Schneider paragraph 0038-0041 & annotated figure below]. PNG media_image3.png 454 550 media_image3.png Greyscale Regarding claim 15, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses wherein the flexible support and donor corneal tissue adopt a rolled shape when retracted into the cannula (Par. 0082 & 0085). Regarding claim 16, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses wherein the removable reservoir encloses the flexible support and cannula when the removable reservoir is removably coupled to the deployment assembly (Par. 0126). Regarding claim 17, Walter, as modified by in the alternative by Schneider, discloses further wherein the removable reservoir further comprises a fluid flow restrictor disposed therein [i.e. inserter cap (300), see Schneider annotated figure below]. PNG media_image4.png 454 550 media_image4.png Greyscale Regarding claim 18, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses wherein at least a portion of the cannula is visually transmissive (Par. 0124). Regarding claim 19, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 1. Walter further discloses wherein a proximal portion of the deployment assembly is slidably engaged to the retractor assembly at a junction, the junction including a one-way valve or gasket that inhibits leakage of the storage fluid (Par. 0122-0123). Regarding claim 20, Walter, as modified by in the alternative by Schneider, discloses the donor corneal tissue storage and delivery device according to claim 19. Walter further discloses (Fig. 8A) wherein the retractor assembly comprises a retractor shaft (16) coupled to the flexible support, and wherein the proximal portion of the deployment assembly is slidably engaged to the retractor shaft at the junction (Par. 0092). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Examiner Chima Igboko whose telephone number is (571)272-8422. The examiner can normally be reached on Monday-Friday 9:00am-6:00pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Jackie Ho, at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /C.U.I/ Examiner, Art Unit 3771 /ASHLEY L FISHBACK/Primary Examiner, Art Unit 3771 January 11, 2026
Read full office action

Prosecution Timeline

Jul 24, 2024
Application Filed
Jan 07, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599499
DEVICES AND METHODS FOR CREATING A CAPSULORHEXIS
2y 5m to grant Granted Apr 14, 2026
Patent 12569362
DELIVERY DEVICE AND METHOD OF DELIVERY
2y 5m to grant Granted Mar 10, 2026
Patent 12569332
IOL INJECTOR WITH AUTOMATIC DRIVER OR ASSISTED MANUAL DRIVE FORCE
2y 5m to grant Granted Mar 10, 2026
Patent 12569327
INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICE
2y 5m to grant Granted Mar 10, 2026
Patent 12558096
FULL EVERSION ANASTOMOSIS JUNCTURE FORMATION AND SUTURING
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+40.8%)
3y 6m
Median Time to Grant
Low
PTA Risk
Based on 408 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month